Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial
- 1 November 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 374 (9703) , 1754-1764
- https://doi.org/10.1016/s0140-6736(09)61492-6
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Heart, Lung, and Blood Institute
This publication has 27 references indexed in Scilit:
- Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate aloneCurrent Medical Research and Opinion, 2008
- A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroidsBritish Journal of Pharmacology, 2008
- Arg16Gly Polymorphism of the β2-adrenergic Receptor Gene Does Not Modulate Clinical Response to Salmeterol in Subjects with AsthmaJournal of Allergy and Clinical Immunology, 2008
- Sequence, Haplotype, and Association Analysis ofADRβ2in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialPublished by Elsevier ,2004
- Effect of Polymorphism of the β2-Adrenergic Receptor on Response to Regular Use of Albuterol in AsthmaInternational Archives of Allergy and Immunology, 2001
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Review papers : Longitudinal studies with continuous responsesStatistical Methods in Medical Research, 1992